Recruiting

The Memory Disorders Program is currently recruiting for the following studies.

Status Title Trial Information Sponsor
Recruiting

DOD-ADNI: A Study of Brain Aging in Vietnam War Veterans

Trial

ADCS
Recruiting

Anti-Amyloid Treatment in Asymptomatic Alzheimer’s Disease (A4)

Trial ADCS and Eli Lilly and Company
Recruiting

Impact of Nilotinib on Safety, Biomarkers and Clinical Outcomes in Mild to Moderate Alzheimer's Disease 

Trial

Georgetown University

Recruiting

Study to Examine the Safety and Efficacy of Pimavanserin for the Treatment of Agitation and Aggression in Alzheimer's Disease (SERENE)

Trial Acadia
Recruiting

221AD302 Phase 3 Study of Aducanumab (BIIB037) in Early Alzheimer's Disease (EMERGE)

Trial Biogen MA Inc.
Recruiting

An Efficacy and Safety Study of LY3314814 in Early Alzheimer's Disease (AMARANTH)

Trial Eli Lilly & Company
Recruiting

A Study of CAD106 and CNP520 Versus Placebo in Participants at Risk for the Onset of Clinical Symptoms of Alzheimer's Disease (GENERATION1)

Trial Novartis
Upcoming

Memory Improvement Through Nicotine Dosing (MIND) Study (MIND)

Trial ATRI
Upcoming

An Efficacy and Safety Study of JNJ-54861911 in Participants Who Are Asymptomatic at Risk for Developing Alzheimer's Dementia (EARLY) (A5)

Trial  Janssen
 Upcoming

Alzheimer's Disease Neuroimaging Initiative 3 (ADNI3) Protocol (ADNI3)

Trial ATRI

For information on participating in our recruiting studies, please see the main Research page.